Drug companies are making good on their vow to post their prices online, part of an attempt to keep the Trump administration from imposing even more stringent rules on price transparency, Bloomberg reports.
The bottom line: This is a response to the administration's proposal to require drugmakers to include list prices in TV ads. Some experts say that making patients go online is not the equivalent of requiring TV ad disclosures. "If your aim is transparency, those prices need to be upfront and not require additional action from the patient," Connecture's Jim Yocum told Bloomberg.
